Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Cufer T

Collect these papers and discover other ones on Labmeeting. Learn more.

International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.

+ cite this

+ View Abstract

Cardoso F, Bedard PL, Winer EP, Pagani O, Senkus-Konefka E, Fallowfield LJ, Kyriakides S, Costa A, Cufer T, Albain KS, and ESO-MBC Task Force

Journal of the National Cancer Institute 101(17):1174-81, 2009 Sep 2 - Who cited this? | PubMed ID: 19657108 | Fulltext

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.

+ cite this

+ View Abstract

Zhang Y, Sieuwerts AM, McGreevy M, Casey G, Cufer T, Paradiso A, Harbeck N, Span PN, Hicks DG, Crowe J, Tubbs RR, Budd GT, Lyons J, Sweep FC, Schmitt M, Schittulli F,

(show remaining authors)

Breast cancer research and treatment 116(2):303-9, 2009 Jul - Who cited this? | PubMed ID: 18821012 | Fulltext

Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.

+ cite this

+ View Abstract

von Minckwitz G, du Bois A, Schmidt M, Maass N, Cufer T, de Jongh FE, Maartense E, Zielinski C, Kaufmann M, Bauer W, Baumann KH, Clemens MR, Duerr R, Uleer C, Andersson M, Stein RC,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(12):1999-2006, 2009 Apr 20 - Who cited this? | PubMed ID: 19289619 | Fulltext

Adjuvant endocrine therapy for perimenopausal women with early breast cancer.

+ cite this

+ View Abstract

Ortmann O, Cufer T, Dixon JM, Maass N, Marchetti P, Pagani O, Pronzato P, Semiglazov V, Spano JP, Vrdoljak E, and Wildiers H

Breast (Edinburgh, Scotland) 18(1):2-7, 2009 Feb - Who cited this? | PubMed ID: 19036588 | Fulltext

Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).

+ cite this

+ View Abstract

Aebersold R, Auffray C, Baney E, Barillot E, Brazma A, Brett C, Brunak S, Butte A, Califano A, Celis J, Cufer T, Ferrell J, Galas D, Gallahan D, Gatenby R, Goldbeter A,

(show remaining authors)

Molecular oncology 3(1):9-17, 2009 Feb - Who cited this? | PubMed ID: 19383362 | Fulltext

Current controversies in extended adjuvant endocrine therapy for early breast cancer.

+ cite this

+ View Abstract

Snoj N, Paridaens R, and Cufer T

Current opinion in oncology 20(6):627-33, 2008 Nov - Who cited this? | PubMed ID: 18841043 | Fulltext

Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

+ cite this

+ View Abstract

Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, Kristiansen G, Paradiso A, Hartmann O, Margossian A, Martens J, Schwope I, Lukas A, Müller V, Milde-Langosch K, Nährig J,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(31):5036-42, 2008 Nov 1 - Who cited this? | PubMed ID: 18711169 | Fulltext

Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group.

+ cite this

+ View Abstract

Paridaens RJ, Dirix LY, Beex LV, Nooij M, Cameron DA, Cufer T, Piccart MJ, Bogaerts J, and Therasse P

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(30):4883-90, 2008 Oct 20 - Who cited this? | PubMed ID: 18794551 | Fulltext

S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.

+ cite this

+ View Abstract

Gazic B, Pizem J, Bracko M, Cufer T, Borstnar S, Pohar-Marinsek Z, and Us-Krasovec M

Cytopathology : official journal of the British Society for Clinical Cytology 19(5):294-302, 2008 Oct - Who cited this? | PubMed ID: 18070112 | Fulltext

Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? The 2007 St Gallen guidelines and/or Adjuvant! Online.

+ cite this

Cufer T

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 19 Suppl 7:vii41-5, 2008 Sep - Who cited this? | PubMed ID: 18790977 | Fulltext

The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study.

+ cite this

+ View Abstract

Golouh R, Cufer T, Sadikov A, Nussdorfer P, Usher PA, Brünner N, Schmitt M, Lesche R, Maier S, Timmermans M, Foekens JA, and Martens JW

Breast cancer research and treatment 110(2):317, 2008 Jul - Who cited this? | PubMed ID: 17874182 | Fulltext

Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial.

+ cite this

+ View Abstract

Pajk B, Cufer T, Canney P, Ellis P, Cameron D, Blot E, Vermorken J, Coleman R, Marreaud S, Bogaerts J, Basaran G, and Piccart M

Breast (Edinburgh, Scotland) 17(2):180-5, 2008 Apr - Who cited this? | PubMed ID: 17976988 | Fulltext

The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients.

+ cite this

+ View Abstract

Zielinski CC, Awada A, Cameron DA, Cufer T, Martin M, and Aapro M

European journal of cancer (Oxford, England : 1990) 44(3):353-65, 2008 Feb - Who cited this? | PubMed ID: 18191396 | Fulltext

Reducing the risk of late recurrence in hormone-responsive breast cancer.

+ cite this

+ View Abstract

Cufer T

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 18 Suppl 8:viii18-viii25, 2007 Sep - Who cited this? | PubMed ID: 17890210 | Fulltext

Guidelines on the standards for the training of specialised health professionals dealing with breast cancer.

+ cite this

+ View Abstract

Cataliotti L, De Wolf C, Holland R, Marotti L, Perry N, Redmond K, Rosselli Del Turco M, Rijken H, Kearney N, Ellis IO, Di Leo A, Orecchia R, Noel A, Andersson M, Audretsch W, Bjurstam N,

(show remaining authors)

European journal of cancer (Oxford, England : 1990) 43(4):660-75, 2007 Mar - Who cited this? | PubMed ID: 17276672 | Fulltext

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.

+ cite this

+ View Abstract

Morales L, Canney P, Dyczka J, Rutgers E, Coleman R, Cufer T, Welnicka-Jaskiewicz M, Nortier J, Bogaerts J, Therasse P, Paridaens R, European Organisation for Research and Treatment of Cancer Breast Group, and Scottish Breast Cancer Trials Group

European journal of cancer (Oxford, England : 1990) 43(2):331-40, 2007 Jan - Who cited this? | PubMed ID: 17134892 | Fulltext

Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: a Slovenian perspective.

+ cite this

+ View Abstract

Piskur P, Sonc M, Cufer T, Borstnar S, and Mrhar A

Anti-cancer drugs 17(6):719-24, 2006 Jul - Who cited this? | PubMed ID: 16917219 | Fulltext

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

+ cite this

+ View Abstract

Foekens JA, Atkins D, Zhang Y, Sweep FC, Harbeck N, Paradiso A, Cufer T, Sieuwerts AM, Talantov D, Span PN, Tjan-Heijnen VC, Zito AF, Specht K, Hoefler H, Golouh R, Schittulli F,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24(11):1665, 2006 Apr 10 - Who cited this? | PubMed ID: 16505412 | Fulltext

Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer.

+ cite this

+ View Abstract

Cufer T, Vrdoljak E, Gaafar R, Erensoy I, Pemberton K, and SIGN Study Group

Anti-cancer drugs 17(4):401-9, 2006 Apr - Who cited this? | PubMed ID: 16549997 | Fulltext

Adjuvant chemotherapy in 2005: standards and beyond.

+ cite this

+ View Abstract

Piccart MJ, de Valeriola D, Dal Lago L, de Azambuja E, Demonty G, Lebrun F, Bernard-Marty Ch, Colozza M, and Cufer T

Breast (Edinburgh, Scotland) 14(6):439-45, 2005 Dec - Who cited this? | PubMed ID: 16188441 | Fulltext

Proteases and metastasis: clinical relevance nowadays?.

+ cite this

+ View Abstract

Decock J, Paridaens R, and Cufer T

Current opinion in oncology 17(6):545-50, 2005 Nov - Who cited this? | PubMed ID: 16224231 | Fulltext

Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial.

+ cite this

+ View Abstract

Bottomley A, Therasse P, Piccart M, Efficace F, Coens C, Gotay C, Welnicka-Jaskiewicz M, Mauriac L, Dyczka J, Cufer T, Lichinitser MR, Schornagel JH, Bonnefoi H, Shepherd L, European Organisation for Research and Treatment of Cancer Breast Cancer Group, National Cancer Institute of Canada,

(show remaining authors)

The lancet oncology 6(5):287-94, 2005 May - Who cited this? | PubMed ID: 15863376 | Fulltext

Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer.

+ cite this

+ View Abstract

Kragelj B, Zaletel-Kragelj L, Sedmak B, Cufer T, and Cervek J

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 75(1):44-7, 2005 Apr - Who cited this? | PubMed ID: 15878100 | Fulltext

Prognostic and predictive value of cathepsins D and L in operable breast cancer patients.

+ cite this

+ View Abstract

Jagodic M, Vrhovec I, Borstnar S, and Cufer T

Neoplasma 52(1):1-9, 2005 - Who cited this? | PubMed ID: 15739019 | Fulltext

Imaging of pleural fluid in healthy individuals.

+ cite this

+ View Abstract

Kocijancic I, Kocijancic K, and Cufer T

Clinical radiology 59(9):826-9, 2004 Sep - Who cited this? | PubMed ID: 15351248 | Fulltext

Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.

+ cite this

+ View Abstract

Efficace F, Therasse P, Piccart MJ, Coens C, Van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Sprangers MA, and Bottomley A

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22(16):3381, 2004 Aug 15 - Who cited this? | PubMed ID: 15310784 | Fulltext

Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Re.

+ cite this

+ View Abstract

Bottomley A, Biganzoli L, Cufer T, Coleman RE, Coens C, Efficace F, Calvert HA, Gamucci T, Twelves C, Fargeot P, Piccart M, and

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22(13):2576, 2004 Jul 1 - Who cited this? | PubMed ID: 15226325 | Fulltext

Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer.

+ cite this

+ View Abstract

Rebersek M, Cufer T, Cemazar M, Kranjc S, and Sersa G

Anti-cancer drugs 15(6):593-7, 2004 Jul - Who cited this? | PubMed ID: 15205602 | Fulltext

Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.

+ cite this

+ View Abstract

Efficace F, Biganzoli L, Piccart M, Coens C, Van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A, and EORTC-BCG-IDBBC-NDDG

European journal of cancer (Oxford, England : 1990) 40(7):1021-30, 2004 May - Who cited this? | PubMed ID: 15093577 | Fulltext

The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.

+ cite this

+ View Abstract

Atalay G, Dirix L, Biganzoli L, Beex L, Nooij M, Cameron D, Lohrisch C, Cufer T, Lobelle JP, Mattiaci MR, Piccart M, and Paridaens R

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 15(2):211-7, 2004 Feb - Who cited this? | PubMed ID: 14760111 | Fulltext

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.

+ cite this

+ View Abstract

Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, Calvert AH, Gamucci T, Minisini A, Therasse P, Piccart MJ, and EORTC Breast Cancer and Early Clinical Studies Groups

European journal of cancer (Oxford, England : 1990) 39(17):2439-49, 2003 Nov - Who cited this? | PubMed ID: 14602130 | Fulltext

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.

+ cite this

+ View Abstract

Paridaens R, Dirix L, Lohrisch C, Beex L, Nooij M, Cameron D, Biganzoli L, Cufer T, Duchateau L, Hamilton A, Lobelle JP, Piccart M, and European Organization for the Research and Treatment of Cancer (EORTC)- Investigational Drug Branch for Breast Cancer (IDBBC)

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 14(9):1391-8, 2003 Sep - Who cited this? | PubMed ID: 12954578 | Fulltext

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients.

+ cite this

+ View Abstract

Look M, van Putten W, Duffy M, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Fred Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brünner N,

(show remaining authors)

Thrombosis and haemostasis 90(3):538-48, 2003 Sep - Who cited this? | PubMed ID: 12958624 | Fulltext

An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer.

+ cite this

+ View Abstract

Bonnefoi H, Biganzoli L, Mauriac L, Cufer T, Schaefer P, Atalay G, and Piccart M

European journal of cancer (Oxford, England : 1990) 39(9):1277-83, 2003 Jun - Who cited this? | PubMed ID: 12763217 | Fulltext

Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study.

+ cite this

+ View Abstract

Therasse P, Mauriac L, Welnicka-Jaskiewicz M, Bruning P, Cufer T, Bonnefoi H, Tomiak E, Pritchard KI, Hamilton A, Piccart MJ, and EORTC

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 21(5):843-50, 2003 Mar 1 - Who cited this? | PubMed ID: 12610183 | Fulltext

Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer.

+ cite this

+ View Abstract

Cufer T, Borstnar S, and Vrhovec I

The International journal of biological markers 18(2):106-15, 2003 - Who cited this? | PubMed ID: 12841679 | Fulltext

Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial.

+ cite this

+ View Abstract

Biganzoli L, Cufer T, Bruning P, Coleman RE, Duchateau L, Rapoport B, Nooij M, Delhaye F, Miles D, Sulkes A, Hamilton A, and Piccart M

Cancer 97(1):40-5, 2003 Jan 1 - Who cited this? | PubMed ID: 12491503 | Fulltext

Constitutional alterations of the ATM gene in early onset sporadic breast cancer.

+ cite this

Maillet P, Bonnefoi H, Vaudan-Vutskits G, Pajk B, Cufer T, Foulkes WD, Chappuis PO, and Sappino AP

Journal of medical genetics 39(10):751-3, 2002 Oct - Who cited this? | PubMed ID: 12362033 | Fulltext

Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.

+ cite this

+ View Abstract

Biganzoli L, Cufer T, Bruning P, Coleman R, Duchateau L, Calvert AH, Gamucci T, Twelves C, Fargeot P, Epelbaum R, Lohrisch C, and Piccart MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20(14):3114-21, 2002 Jul 15 - Who cited this? | PubMed ID: 12118025 | Fulltext

Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.

+ cite this

+ View Abstract

Borstnar S, Vrhovec I, Svetic B, and Cufer T

Clinical breast cancer 3(2):138-46, 2002 Jun - Who cited this? | PubMed ID: 12123538 | Fulltext

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

+ cite this

+ View Abstract

Awada A, Biganzoli L, Cufer T, Beex L, Lohrisch C, Batter V, Hamilton A, Nooij M, and Piccart M

European journal of cancer (Oxford, England : 1990) 38(6):773-8, 2002 Apr - Who cited this? | PubMed ID: 11937310 | Fulltext

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

+ cite this

+ View Abstract

Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brünner N,

(show remaining authors)

Journal of the National Cancer Institute 94(2):116-28, 2002 Jan 16 - Who cited this? | PubMed ID: 11792750 | Fulltext

Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival.

+ cite this

+ View Abstract

Cufer T, Vrhovec I, and Borstnar S

The International journal of biological markers 17(1):33-41, 2002 - Who cited this? | PubMed ID: 11936584 | Fulltext

Prognostic value of plasminogen activator inhibitors in breast cancer.

+ cite this

+ View Abstract

Borstnar S, Vrhovec I, and Cufer T

The International journal of biological markers 17(2):96-103, 2002 - Who cited this? | PubMed ID: 12113588 | Fulltext

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.

+ cite this

+ View Abstract

Bonnefoi H, Biganzoli L, Cufer T, Mauriac L, Hamilton A, Schaefer P, and Piccart M

Breast cancer research and treatment 70(1):55-63, 2001 Nov - Who cited this? | PubMed ID: 11768362 | Fulltext

Selection of candidates for oral etoposide salvage chemotherapy in heavily pretreated breast cancer patients.

+ cite this

+ View Abstract

Jagodic M, Cufer T, Zakotnik B, and Cervek J

Anti-cancer drugs 12(3):199-204, 2001 Mar - Who cited this? | PubMed ID: 11290866 | Fulltext

Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma.

+ cite this

+ View Abstract

Bracko M, Us-Krasovec M, Cufer T, Lamovec J, Zidar A, and Goehde W

Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 23(1):56-66, 2001 Feb - Who cited this? | PubMed ID: 11233744 | Fulltext

Cytological grading of breast cancer in Giemsa-stained fine needle aspiration smears.

+ cite this

+ View Abstract

Skrbínc B, Babic A, Cúfer T, and Us-Krásovec M

Cytopathology : official journal of the British Society for Clinical Cytology 12(1):15-25, 2001 Feb - Who cited this? | PubMed ID: 11256933 | Fulltext

Myeloid metaplasia of the breast.

+ cite this

+ View Abstract

Cufer T and Bracko M

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 12(2):267-70, 2001 Feb - Who cited this? | PubMed ID: 11300336 | Fulltext

Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancer.

+ cite this

+ View Abstract

Zwitter M, Cufer T, and Wein W

Neoplasma 48(3):200-2, 2001 - Who cited this? | PubMed ID: 11583289 | Fulltext

Search Google Scholar for Cufer T

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.